Skip to main content

Jose Ramon Conejo-Garcia

Professor in Integrative Immunobiology
Integrative Immunobiology
2128 Msrbiii, 3 Genome Ct, Durham, NC 27710

Research Interests


Currently funded studies include the following interests:

1-Spontaneous humoral anti-tumor immunity, including the formation of Tertiary Lymphoid Structures
2-Novel antibody-based immunotherapies
3-Crosstalk between butyrophilins and gamma/delta T cells in human cancer
4-Dark matter, unconventional cancer antigens
5-Empowering CAR T cells to become effective in epithelial tumors
6-T cell lymphoma

Selected Grants


Inter-metastatic divergency in small cell lung cancer; implications for the design of future immunotherapies

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028

Basic Immunology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025

Time restricted eating to improve immunotherapy outcomes in African American patients with Head and Neck cancer.

ResearchMentor · Awarded by Bristol-Myers Squibb Foundation · 2024 - 2025

Evaluation of time restricted eating in improving immunotherapy response.

ResearchCollaborator · Awarded by Biocodex Microbiota Foundation · 2024 - 2024

Olfactory receptor OR2H1 as an effective target for CAR T cells in human epithelial tumors

ResearchPrincipal Investigator · Awarded by Cancer Research Institute · 2023 - 2024

Inter-metastatic divergency in small cell lung cancer; implications for the design of future immunotherapies

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028

Basic Immunology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025

Time restricted eating to improve immunotherapy outcomes in African American patients with Head and Neck cancer.

ResearchMentor · Awarded by Bristol-Myers Squibb Foundation · 2024 - 2025

Evaluation of time restricted eating in improving immunotherapy response.

ResearchCollaborator · Awarded by Biocodex Microbiota Foundation · 2024 - 2024

Olfactory receptor OR2H1 as an effective target for CAR T cells in human epithelial tumors

ResearchPrincipal Investigator · Awarded by Cancer Research Institute · 2023 - 2024

Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2024

B cell-dependent anti-tumor immunity in ovarian cancer

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2024

External Relationships


  • Alloy Therapeutics
  • Anixa Biosciences
  • Cellepus Therapeutics
  • Compass Therapeutics
  • Mays Cancer Center at UT San Antonio
  • Alloy Therapeutics
  • Anixa Biosciences
  • Cellepus Therapeutics
  • Compass Therapeutics
  • Mays Cancer Center at UT San Antonio
  • National Cancer Institute
  • University of Louisville COBRE
  • University of Pittsburgh Spore in ovarian cancer

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.